A Comparison of Serum and Sputum Inflammatory Mediator Profiles in Patients with Asthma and COPD
J Int Med Res 6;40 (2012):2231 – 2242
Y Cao1, W Gong2, H Zhang3, B Liu4, B Li5, X Wu6, X Duan7, J Dong8,
1,2,3,4,5,6,7,8Department of Integrated Traditional Chinese and Western Medicine, Huashan Hospital, Fudan University, Shanghai, China
OBJECTIVE: To investigate serum and sputum cytokine profiles in asthma and chronic obstructive pulmonary disorder (COPD). METHODS: Clinical characteristics, blood and sputum samples were collected from asthma (n = 37) and COPD (n = 36) patients, and healthy subjects (n = 39). Cytokines were measured by enzyme-linked immunosorbent assay (ELISA) and inflammation antibody array; levels were analysed according to smoking status and presence of eosinophilia in the airways of COPD/asthma patients, and compared with those in healthy subjects. RESULTS: ELISA revealed a significant difference in the expression of only a few cytokines in the COPD versus asthma groups, and in both patient groups compared with healthy subjects. The antibody array showed greater differentiation in inflammatory mediators. In the subphenotype analysis, the differential expression of cytokines was more significant between eosinophilic and noneosinophilic airway inflammation than between asthma and COPD, according to both the ELISA and antibody array. There was little difference in cytokine expression between smoking and nonsmoking subgroups. CONCLUSIONS: Differential expression of inflammatory mediators is present between patients with COPD or asthma, and eosinophilic or noneosinophilic airway inflammation, and contributes to understanding the cytokine network of airway inflammation.
Online citation
Article type
Research Report
Topics
Chemical Pathology, Respiratory Diseases, Respiratory Medicine
Keywords
AIRWAY INFLAMMATION, ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD), CYTOKINE
No comments:
Post a Comment